CSIMarket



Eli Lilly And Company  (LLY)
Other Ticker:  
 

Eli Lilly's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Change 29.95 % 33.28 % 57.16 % 59.21 % -
Y / Y Net Income Change -31.48 % 40.4 % -18.46 % -8.13 % -1.54 %
Net Income (TTM) in Millions 5,692 6,129 5,582 5,972 6,071
Return On Equity (TTM) 64.62 % 73.77 % 72.32 % 86.74 % 98.77 %
Total Ranking # 171 # 143 # 156 # 122 # 120
Equity (TTM) in Millions 8,659 9,462 9,155 7,954 6,664
Seq. Equity Change -8.48 % 3.36 % 15.1 % 19.37 % -6.14 %
Seq. Net Income Change -49.94 % 10.24 % 55.49 % -20.15 % 2.58 %


Roe Comment
Eli Lilly And Company returned in II. Quarter 64.62 % on shareholder's equity, and it was higher than Eli Lilly average return on equity.

ROE decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 28 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 144 to 171.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 12
Sector # 29
Overall # 171

Return On Equity Statistics
High Average Low
287.25 %
46.64 %
3.46 %
(Dec 31 2019)   (Sep 30 2018)


Annual Return On Equity (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Equity in Millions 9,155 5,825 2,699 10,909 11,668
Y / Y Equity Change 57.16 % 115.82 % -75.26 % -6.5 % -17.13 %
Net Income in Millions 5,582 6,194 8,318 3,232 -204
Y / Y Net Income Change -9.88 % -25.54 % 157.38 % - -
Return On Equity 60.97 % 106.33 % 308.19 % 29.63 % -1.75 %





Annual Roe Comment
In 2021 ROE decreased compare to previous year to 60.97 %, due to detoriation of net income.


Financial Statements
Eli Lilly's Equity $ 8,659 Millions LLY's Balance sheet
Eli Lilly's Income $ 953 Millions Quarterly LLY's Income Statement
LLY's Income by Division See LLY's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
LLY's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for LLY's Competitors
Return On Equity for Eli Lilly's Suppliers
Roe for LLY's Customers

You may also want to know
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Statistics
LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roi LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Dividend Payout Ratio



Companies with similar Return On Equity at Jun 30 2022, within Healthcare Sector ROE
Molecular Templates Inc.  164.06 %
Dariohealth Corp.  145.53 %
Amgen Inc.  144.12 %
Halozyme Therapeutics Inc.  138.69 %
Effector Therapeutics Inc.  121.96 %
Aptevo Therapeutics Inc.  109.76 %
Avid Bioservices Inc.  106.62 %
Idexx Laboratories Inc  104.46 %
Davita Inc.  104.44 %
Ironwood Pharmaceuticals inc.  97.65 %
Moderna Inc.  94.76 %
Maravai Lifesciences Holdings Inc.  92.73 %
Dynavax Technologies Corporation  91.34 %
Journey Medical Corporation  85.14 %
Selecta Biosciences Inc  85.07 %
Abbvie Inc.  84.29 %
Biomx Inc.  83.21 %
Vicarious Surgical Inc.  82.59 %
Avalo Therapeutics Inc.  81.00 %
Harpoon Therapeutics Inc.  80.40 %
Sensus Healthcare Inc.  74.85 %
Tenet Healthcare Corp  74.11 %
Vir Biotechnology Inc.  68.86 %
Oncotelic Therapeutics Inc.  68.05 %
Biofrontera Inc.  65.87 %
Eli Lilly And Company  64.62 %
Iteos Therapeutics Inc.  60.26 %
180 Life Sciences Corp.  59.53 %
Vyne Therapeutics Inc.  54.91 %
Siga Technologies Inc  48.79 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KALO's Profile

Stock Price

KALO's Financials

Business Description

Fundamentals

Charts & Quotes

KALO's News

Suppliers

KALO's Competitors

Customers & Markets

Economic Indicators

KALO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071